Home > Products > Human Tumor Cell Lines >

RPMI 2650

Product Name

RPMI 2650

Price Get Quote
Product Code

RPMI-2650

Cat.No

ABC-TC0984

Species

Human

Size/Quantity

1 vial

Biosafety Level

1

Shipping Info

Dry Ice

Storage

Liquid Nitrogen

Description

Derived from the nasal septum of a 52-year-old male patient afflicted with squamous cell carcinoma, RPMI 2650 is an epithelial cell line characterized by its distinctive morphological features. Immunoperoxidase staining confirms their positive keratin status. Mimicking the structure of nasal mucosa, these cells assemble into a polarized epithelium and showcase the presence of occludin, claudin-1, and E-cadherin, reminiscent of their natural counterparts. Interestingly, cells cultivated at the air-liquid (A-L) interface exhibit enhanced layering, elevated transepithelial electrical resistance (TEER), and reduced dextran and jacalin permeability compared to those at the L-L interface, which present a more differentiated appearance. Remarkably, these cells are proficient in TGF-beta secretion and display heightened responsiveness to stimuli such as HDM allergens and TNF-alpha, prompting amplified TGF-beta gene expression and subsequent protein release.

 

Why choose RPMI 2650 from AcceGen?

RPMI 2650 cells are distinguished by their excellent viability and quality, thriving under optimal incubation conditions. These cells arrive in a sterile state, having undergone advanced cryopreservation techniques, and are subject to rigorous quality control, ensuring reliability and consistency for diverse research needs.

Source Organ

Nose

Recommended Medium And Supplement
Citation Guide

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

FOR RESEARCH USE ONLY

The RPMI 2650 cell line plays a pivotal role in advancing medical research by facilitating early assessments of innovative interventions aimed at addressing irregular reactions of upper airway structural cells. Serving as an in vitro model for nasal mucosa, this cell line proves invaluable for investigating drug permeability and screening potential nasal drug candidates. Moreover, its significance extends to studying the intricate regulation of TGF-beta biology, solidifying RPMI 2650 as a robust tool for enhancing our understanding of various therapeutic strategies.

 

Growth Conditions

37 ℃, 5% CO2

Cell Type

Epithelial

Growth Mode

Adherent

Product Type

Human Other Cell Lines

Product Image AcceGen Frozen Cells & Cell Lines 1 vial
  • ONLINE INQUIRY
  • PRODUCT REVIEWS
We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time?

Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
Privacy Policy: AcceGen will never sell, rent, or share your personal information with any third parties without your express permission.
Reviews of RPMI 2650
AcceGen is always trying to do right by our customers and working hard to build a higher quality product.

Your email address will not be published.

AcceGen Scroll Top Button
Copy link
Powered by Social Snap